🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jasmine M. Zain

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0003-4308-629X
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti−PD-L1 in Cutaneous T-Cell Lymphoma”.

Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti−PD-L1 in Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.02.017
N/A
0.457DataRank · unranked
20 citations

Xiwei Wu, Hanjun Qin, Yate‐Ching Yuan, Jasmine M. Zain, D. Lynne Smith +5 more

Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2023012497
N/A
0.110DataRank · unranked
1 citations

Ni‐Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla, James R. Bading +20 more

Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

American Journal of Hematology(2023)10.1002/ajh.27069
N/A
0DataRank · unranked
34 citations

Stacy Pak, Matthew Mei, Yan Wang, Leslie Popplewell, John H. Baird +13 more

Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma

JCI Insight(2023)10.1172/jci.insight.163518
N/A
0DataRank · unranked
22 citations

Xiwei Wu, Hanjun Qin, Yate‐Ching Yuan, Daniel Schmolze, Chingyu Su +9 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800
N/A
0DataRank · unranked
4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

A Phase II Trial of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2019.12.752
N/A
0DataRank · unranked
2 citations

Ni‐Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Thai M. Cao, Haris Ali +13 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845
N/A
0DataRank · unranked
2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders

JID Innovations(2021)10.1016/j.xjidi.2021.100068
N/A
0DataRank · unranked
12 citations

Weiwei Zhang, Xiwei Wu, K. Honda, Hanjun Qin, Hyejin Cho +7 more